Just Other Articles

It is both good planning and considerate to provide auditors with a

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

guide for their criticism. It would be quite difficult for them to n

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

te everything which needs attention without some reminder of what to

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

look for. A critique is worthless unless it is clinical and objecti

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

e. At this stage, a trainer is looking for what is wrong with their

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

resentation more than for what is right. The critics must be mercile

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ss. (Better them than the audience.)

Criticism should center upon b

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

th the subject matter and the main guidelines of good presenting. Id

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

eally, the critics should read this article as a foundation for thei

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

criticism, but if they have not done so, the following guidelines a

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e designed to give directions to the auditors in what to look for. 1

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

. Attitude: There is appropriate enthusiasm and sincerity, without a

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

pearing egocentric. 2. Content: The information is valid and accurat

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

e. 3. Structure: There is clear evidence of a unified, central struc

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ure which is easy to follow. 4. Introduction: The introduction is at

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ention-getting and says what the presentation contains. 5. Conclusio

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

n: The conclusion ties the information together. 6. Audience Awarene

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

s: They understand and empathize with the audience. 7. Supportive Ma

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

terials: Visuals are clear and easy to see and comprehend. 8. Delive

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

y: Language, diction, and pronunciation are cultured and appropriate

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/34948/justotherarticles-Guidelines-for-Rehearsal-Criticism.html">Guidelines for Rehearsal Criticism</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/34948/justotherarticles-Guidelines-for-Rehearsal-Criticism.html]Guidelines for Rehearsal Criticism[/url]

Planning your fundraiser is the most important part of any successful fundraising campaign.

Have you ever worked for someone who was such a micro-manager that it drove you crazy? And have you ever worked for someone who was so hands-off that you felt like a lone warrior on the battlefield? These are examples of you working for leaders who did not adapt their style based on the employee’s needs. What can you, as a manager, do to prevent the same mistake? My suggestion is to follow what good parents do.

Our culture hinders us from getting our message across as well receiving the full message that others want to convey to us. This article expounds on the main causes for cross-cultural misunderstandings and on the attitudes we need to communicate cross-culturally.

Tags

Links

Just Other Articles - Guidelines for Rehearsal Criticism

Related Articles: